LBT Innovations Ltd (ASX:LBT)
A$ 0.013 0 (0%) Market Cap: 21.45 Mil Enterprise Value: 22.30 Mil PE Ratio: 0 PB Ratio: 6.50 GF Score: 0/100

LBT Innovations Ltd at Sharecafe Hidden Gems Webinar Transcript

May 12, 2023 / NTS GMT
Release Date Price: A$0.027999 (+21.21%)
Brent Barnes
LBT Innovations Limited - CEO, Managing Director

Look, I want to start with our mission. We are disrupting microbiology culture plate reading. It's really simple. It's really specific. And that's because the microbiology market is huge and it's really ripe for disruption.

So if we go to first slide after the disclaimer, I really wanted to wrap up the investment highlights in one slide just to get your attention if you like. We are a commercial-stage company. We are generating revenue. Our technology, back to our mission, automates culture plate reading in microbiology.

It's a validated hardware platform as well as an AI capability. Importantly, it's a single platform and architecture and we're focused at the moment on two really major markets, it's clinical microbiology and pharmaceutical quality control microbiology.

And when you look at each of those markets, we have really big companies that are backing that technology. Thermo Fisher are our exclusive distributors for APAS in the clinical market. AstraZeneca is funding as well as partnering with us for the pharma

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot